Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2007 | 09-2006 | 06-2006 | |
| Operating Expenses | 10,232 | 10,753 | 9,471 |
| Operating Income | -10,232 | -10,753 | -9,471 |
| Interest Expense | 92 | 75 | 74 |
| Other Income | 629 | -815 | 921 |
| Pre-tax Income | -9,695 | -11,643 | -8,624 |
| Net Income Continuous | -9,695 | -11,643 | -8,624 |
| Net Income | $-9,695 | $-11,643 | $-8,624 |
| EPS Basic Total Ops | -10.21 | -15.01 | -39.04 |
| EPS Basic Continuous Ops | -10.16 | -14.95 | -11.98 |
| EPS Diluted Total Ops | -10.21 | -15.01 | -39.04 |
| EPS Diluted Continuous Ops | -10.16 | -14.95 | -11.98 |
| EBITDA(a) | $-9,935 | $-10,508 | $-9,471 |